Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Tendon-Bone Healing in ACL Reconstruction
NCT04659447Phase 1Unknown
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Jul 2016
- Primary completion
- Nov 2021
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Phase 1, randomised, open-label trial of platelet-rich plasma in anterior cruciate ligament injury (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoints: Tendon-bone healing at 1 year, Ligament maturation at 1 year and 5 more. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT04659447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04659447.